Retrospective study investigating naloxone prescribing and cost in US Medicaid and Medicare patients

Conclusions
This pronounced increase in the number of naloxone prescriptions to Medicaid patients from 2018 to 2021 indicates a national response to this widespread public health emergency. Further research into the origins of the pronounced state-level disparities is warranted.

Source: BMJ Open - May 1, 2024 Category: General Medicine Authors: Manko, C. D., Ahmed, M. S., Harrison, L. R., Kodavatiganti, S. A., Lugo, N., Konadu, J. O., Khan, F., Massari, C. A., Sealey, T. K., Addison, M. E., Mbah, C. N., McCall, K. L., Fraiman, J. B., Piper, B. J. Tags: Open access, Pharmacology and therapeutics Source Type: research